Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced publishing seven new volumes of New and Future Developments in Catalysis edited by Steven Suib. These will be first presented here in Indianapolis at Chemistry in Motion, the American Chemical Society’s annual meeting held September 8-12.
The seven volumes compile the latest ideas regarding biofuels and the production of chemicals with less damage to the environment, as well as a comprehensive summary of past, current, and future research on efficient, sustainable and clean catalytic processes. Editor Steven Suib is a leader in solid-state catalysis and renewable energy systems in the US with 450 articles and 40 patents to his name. He has also authored multiple books on the topic of catalysis and serves as an editor for Elsevier journal Microporous and Mesoporous Materials.
The full titles of the seven new volumes are:
New and Future Developments in Catalysis: Catalytic Biomass Conversion
New and Future Developments in Catalysis: Activation of Carbon Dioxide
New and Future Developments in Catalysis: Solar Photocatalysis
New and Future Developments in Catalysis: Catalysis for Remediation and Environmental Concerns
New and Future Developments in Catalysis: Catalysis by Nanoparticles
New and Future Developments in Catalysis: Batteries, Hydrogen Storage, and Fuel Cells
New and Future Developments in Catalysis: Hybrid Materials, Composites, and Organocatalysts
All titles listed above are available through the Elsevier Store or can be found on ScienceDirect, Elsevier’s full-text scientific database offering journal articles and book chapters from more than 2,500 peer-reviewed journals and almost 20,000 book titles.
This week Elsevier also launched a Chemical Reaction Books Portfolio on ScienceDirect. The custom-curated online portfolio includes 474 books with foundational and applied content across three sub-disciplines: chemistry and polymers; oil and gas; and pharmaceuticals and biotechnology. Handpicked by pharmaceutical and biotechnology editors from Elsevier and Reaxys, it offers chemists and business stakeholders technical, economic and commercial resources to lead research and development, while maximizing productivity, efficiency and discovery.
